Long-acting opioids and short- acting opioids: appropriate use in chronic pain management. Pain Med. 2009;10 Suppl 2:S79-S88.Fine PG, Mahajan G, McPherson ML (2009) Long-acting opioids and short-acting opioids: appropriate use in chronic pain management. Pain Med. 10 Suppl 2: S79-88....
Long‐Acting Opioids and Short‐Acting Opioids: Appropriate Use in Chronic Pain Management In recent years, opioid therapy for the management of chronic noncancer pain has become more widely accepted following the publication of data demonstratin... PG Fine,G Mahajan,ML Mcpherson - 《Pain Medicine...
However, in general, the patients who previously had overused short-acting opioids were more likely to overuse the long-acting ones. Twenty-four patients (8 percent) qualified for 'prescription opiate abuse,' necessitating discontinuation of the medication. Patients more likely to abuse the ...
Many cancer patients experience chronic and breakthrough pain necessitating the use of both immediate release (IR) and extended release (ER) opioids. The common strategy in treating chronic cancer pain is using ER opioids with the addition of IR opioids for breakthrough pain. The National Comprehen...
Prescription opioid analgesics, particularly short-acting opioids, are misused and abused by excessive ingestion of intact tab-lets, and by intranasal and ... S Daniels,F Clark,R Spivey,... - 《Journal of Pain》 被引量: 6发表: 2009年 加载更多来源...
Codeine remained the most commonly used opioid at 1 year after surgery (87.5%), but long-term opioid users also used more potent long-acting opioids, including transdermal fentanyl (1.6%) and oxycodone (15.9%). Among the early users group, those who received a prescription within 60 days of...
9,19,32 Of particular concern is our finding that a high proportion (81.8%) of adults who use both drugs concurrently for a long term are prescribed stimulants and short-acting opioids. Short-acting opioids are recommended for acute pain, but their long-term use has been discouraged by ...
Patient Safety and Extended Release/Long-Acting Opioids [CME}Discusses the FDA's Risk Evaluation and Mitigation Strategy (REMS) for extended-release and long-acting (ER/LA) opioid analgesics.Katherine E. Galluzzi
5 Consequently, although most patients are prescribed IR opioids for short-term treatment (<14 days),5 given the large number of patients prescribed IR opioids, the number treated long-term could approach or even exceed the number treated long-term with ER opioids. Additionally, acetaminophen is...
Drugs of abuse, including alcohol, ablate the expression of specific forms of long-term synaptic depression (LTD) at glutamatergic synapses in dorsal striatum (DS), a brain region involved in goal-directed and habitual behaviors. This loss of LTD is asso